🇺🇸 Onvansertib in United States

28 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Febrile Neutropenia — 5 reports (17.86%)
  2. Drug Resistance — 4 reports (14.29%)
  3. Hyperphosphataemia — 3 reports (10.71%)
  4. Intestinal Obstruction — 3 reports (10.71%)
  5. Leukopenia — 3 reports (10.71%)
  6. Abdominal Abscess — 2 reports (7.14%)
  7. Abdominal Pain — 2 reports (7.14%)
  8. Alanine Aminotransferase Increased — 2 reports (7.14%)
  9. Aspartate Aminotransferase Increased — 2 reports (7.14%)
  10. Blood Alkaline Phosphatase Increased — 2 reports (7.14%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Onvansertib approved in United States?

Onvansertib does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Onvansertib in United States?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.